title: Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.
abstract: FDG-PET imaging is more frequently being used to stage malignant Lymphoma and monitor response to therapy. However, FDG-PET is not a tumor specific substance and increased accumulation may be seen in a variety of benign entities, our case exemplifies this problem and underline the importance of a biopsy.
authors.affiliation: Department of 1Oncology, University of Messina, Italy. pitini@ciaoweb.it
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Pitini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Navarra
authors.forename: Vittorio
authors.initials: V
authors.lastname: Cavallari
authors.forename: Carmela
authors.initials: C
authors.lastname: Arrigo
authors.forename: Claudia
authors.initials: C
authors.lastname: Naro
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Altavilla
mesh_terms: D000075202:Contraindications; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000473:pathology*; D006801:Humans; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals; D012008:Recurrence
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18